PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
26075078-0	2015	MHC class I-related chain B gene polymorphism is associated with virological response to pegylated interferon plus ribavirin therapy in patients with chronic hepatitis C infection.	Ribavirin	115-124	MHC class I polypeptide-related sequence B	Homo sapiens	0-27	
26075078-2	2015	In the present study, the association between MHC class I-related chain B (MICB) genotypes and therapeutic response to pegylated interferon plus ribavirin (PEG-IFN/RBV) therapy was investigated in hepatitis C virus (HCV)-infected patients.	Ribavirin	145-154	MHC class I polypeptide-related sequence B	Homo sapiens	46-73	
26075078-2	2015	In the present study, the association between MHC class I-related chain B (MICB) genotypes and therapeutic response to pegylated interferon plus ribavirin (PEG-IFN/RBV) therapy was investigated in hepatitis C virus (HCV)-infected patients.	Ribavirin	145-154	MHC class I polypeptide-related sequence B	Homo sapiens	75-79	
26075078-2	2015	In the present study, the association between MHC class I-related chain B (MICB) genotypes and therapeutic response to pegylated interferon plus ribavirin (PEG-IFN/RBV) therapy was investigated in hepatitis C virus (HCV)-infected patients.	Ribavirin	164-167	MHC class I polypeptide-related sequence B	Homo sapiens	46-73	
26075078-11	2015	In conclusion, the MICB genotype is a strong predictive factor for virological response to PEG-IFN/RBV therapy in HCV patients.	Ribavirin	99-102	MHC class I polypeptide-related sequence B	Homo sapiens	19-23